Contact Us: 01282 426380
KM Financial Solutions | Celgene readies deal to buy Impact Biomedicines for as much as $7 bln -WSJ
7072
post-template-default,single,single-post,postid-7072,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Celgene readies deal to buy Impact Biomedicines for as much as $7 bln -WSJ

06 Jan Celgene readies deal to buy Impact Biomedicines for as much as $7 bln -WSJ

Posted at 21:06h in News by
0 Likes
NEW YORK, Jan 7 (Reuters) – Celgene Corp is
expected to announce Monday that it is acquiring Impact
Biomedicines for as much as $7 billion, the Wall Street Journal
reported Sunday.

No Comments

Sorry, the comment form is closed at this time.